RDY Latest Press Releases

-- December 2, 2025 --

Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies Business Wire 8:00 AM

-- October 22, 2025 --

Aurigene Oncology to Showcase Innovative A-PROX Platform at the AACR-NCI-EORTC International Conference 2025 Business Wire 12:00 PM

-- August 25, 2025 --

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PRNewswire 8:00 AM

-- August 18, 2025 --

Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Globe Newswire 8:16 AM

-- July 24, 2025 --

DR REDDYS LABORATORIES LTD General Corporate Statement By Foreign Issuer (Form6) Benzinga Newsdesk 7:02 AM

-- July 23, 2025 --

Dr. Reddy's Q1FY26 Financial Results Business Wire 1:46 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software